Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 8/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.35 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.35 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.35 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 2/20 | 0.33 |
| ▸ | CCR8 | P51685 | 2/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13808770 | 0.91 | TOP1 (0.39) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL10353362 | 0.87 | TOP1 (0.37) | TOP1MAPTMAP4K4CCR1CCR8 | |
| SCHEMBL23784955 | 0.86 | TOP1 (0.40) | TOP1CCR1CCR8DHODHL3MBTL1 | |
| SCHEMBL12708926 | 0.84 | CCR1 (0.43) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL12708804 | 0.83 | CCR1 (0.42) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL13808765 | 0.83 | CCR1 (0.44) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL10353574 | 0.81 | CCR1 (0.40) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL23709976 | 0.81 | CCR1 (0.42) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL13808788 | 0.80 | CCR1 (0.41) | TOP1MAPTCCR1CCR8L3MBTL1 | |
| SCHEMBL10353322 | 0.80 | TOP1 (0.43) | TOP1MAPTCCR1CCR8L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10573823-B2 | Organic electroluminescent device | JOLED INC (JP) | 2020-02-25 | — | — | US | disclosed |
| US-9978975-B2 | Organic electroluminescence device | JOLED INC (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9978975-B2 | Organic electroluminescence device | JOLED INC (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20150303380-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MAGNOLIA BLUE CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150303380-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MAGNOLIA BLUE CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150069351-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MAGNOLIA BLUE CORPORATION (JP) | 2015-03-12 | — | — | US | disclosed |
| US-7553558-B2 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY (US) | 2009-06-30 | — | — | US | disclosed |
| US-7553558-B2 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY (US) | 2009-06-30 | — | — | US | disclosed |
| WO-2007064493-A1 | ELECTROLUMINESCENT DEVICE CONTAINING AN ANTHRACENE DERIVATIVE | EASTMAN KODAK COMPANY (US) | 2007-06-07 | — | — | WO | disclosed |
| US-20070122656-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-05-31 | — | — | US | disclosed |
| US-20070122656-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10573823-B2 | Organic electroluminescent device | L1CAM, NES, EML4 | TOP1 3667/4885MAPT 1337/4885MAP4K4 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.